Jan Claassen Selected Research

Anticoagulants

1/2019	ABO Blood Type and Hematoma Expansion After Intracerebral Hemorrhage: An Exploratory Analysis.
4/2017	Chronic Subdural Medical Management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan Claassen Research Topics

Disease

38	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2023 - 01/2006
24	Status Epilepticus (Complex Partial Status Epilepticus) 01/2024 - 02/2002
17	Seizures (Absence Seizure) 01/2022 - 02/2002
16	Coma (Comas) 01/2023 - 11/2002
16	Brain Injuries (Brain Injury) 01/2023 - 11/2002
14	Cerebral Hemorrhage 03/2024 - 04/2010
12	Critical Illness (Critically Ill) 01/2021 - 12/2004
9	Heart Arrest (Cardiac Arrest) 01/2024 - 05/2014
8	Brain Ischemia (Cerebral Ischemia) 07/2019 - 06/2009
6	Hemorrhage 03/2024 - 09/2009
6	Ischemic Stroke 03/2024 - 08/2015
6	Pneumonia (Pneumonitis) 10/2015 - 01/2006
5	Stroke (Strokes) 07/2023 - 04/2011
5	COVID-19 01/2022 - 01/2020
4	Myocardial Infarction 03/2024 - 01/2019
4	Venous Thrombosis (Deep-Vein Thrombosis) 03/2024 - 01/2021
4	Hematoma 11/2020 - 01/2019
4	Clinical Deterioration 04/2020 - 06/2009
4	Hypertension (High Blood Pressure) 04/2020 - 03/2006
4	Heart Failure 01/2020 - 01/2006
4	Edema (Dropsy) 01/2019 - 05/2002
4	Fever (Fevers) 07/2017 - 12/2004
4	Brain Edema (Cerebral Edema) 01/2016 - 04/2010
3	Infections 01/2021 - 01/2008
3	Thrombosis (Thrombus) 01/2021 - 11/2020
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 01/2018
3	Aneurysm (Aneurysms) 01/2019 - 03/2009
3	Inflammation (Inflammations) 01/2018 - 05/2014
3	Hyponatremia 01/2018 - 03/2006
3	Cognitive Dysfunction 06/2017 - 06/2009
3	Anemia 02/2015 - 03/2006
3	Ischemia 08/2011 - 09/2009
3	Hyperglycemia 01/2008 - 01/2006
2	Pulmonary Embolism 03/2024 - 07/2023
2	Consciousness Disorders 01/2021 - 01/2020
2	Lung Diseases (Lung Disease) 04/2020 - 01/2020
2	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 01/2006
2	Unstable Angina 01/2020 - 01/2019
2	Pulmonary Edema 01/2019 - 03/2006
2	Epilepsy (Aura) 01/2019 - 07/2003
2	Hydrocephalus (Hydrocephaly) 01/2019 - 08/2015
2	Out-of-Hospital Cardiac Arrest 01/2018 - 10/2011
2	Sepsis (Septicemia) 10/2017 - 08/2015
2	Urinary Tract Infections (Urinary Tract Infection) 02/2015 - 05/2014
2	Hypotension (Low Blood Pressure) 05/2014 - 03/2006
2	Hypoxia (Hypoxemia) 11/2011 - 08/2010
2	Intracranial Hypertension 08/2011 - 03/2009
2	Infarction (Infarctions) 04/2011 - 06/2009
2	Meningitis 10/2010 - 04/2010
2	Spasm (Spasms) 06/2009 - 01/2009
1	Persistent Vegetative State (Vegetative State) 01/2022

Drug/Important Bio-Agent (IBA)

11	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 02/2002
9	Oxygen (Dioxygen)IBA 01/2023 - 03/2009
9	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 01/2010
7	Biomarkers (Surrogate Marker)IBA 04/2020 - 05/2010
5	Lactic Acid (Lactate)FDA LinkGeneric 04/2016 - 06/2010
5	Pyruvic Acid (Pyruvate)IBA 04/2016 - 06/2010
4	Ketamine FDA LinkGeneric 01/2024 - 08/2013
4	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2023 - 08/2011
4	Hemoglobins (Hemoglobin)IBA 01/2023 - 01/2010
3	BenzodiazepinesIBA 01/2022 - 02/2002
3	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2020
3	Anesthetics (Anesthetic Agents)IBA 12/2019 - 07/2002
3	Midazolam (Versed)FDA LinkGeneric 01/2014 - 02/2002
2	Hemostatics (Antihemorrhagics)IBA 03/2024 - 01/2023
2	Interleukin-6 (Interleukin 6)IBA 04/2020 - 01/2020
2	AnticoagulantsIBA 01/2019 - 04/2017
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 04/2010
2	Nicardipine (Dagan)FDA LinkGeneric 05/2016 - 02/2013
2	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2014 - 12/2004
2	Pentobarbital (Nembutal)FDA Link 05/2014 - 02/2002
2	Phenobarbital (Luminal)FDA Link 05/2014 - 02/2002
2	C-Reactive ProteinIBA 05/2014 - 09/2011
2	3,4,4a,10b- tetrahydro- 4- propyl- 2H,5H- (1)benzopyrano(4,3- b)- 1,4- oxazin- 9- olIBA 04/2014 - 04/2011
2	Hypnotics and Sedatives (Sedatives)IBA 01/2007 - 11/2002
2	Propofol (Diprivan)FDA LinkGeneric 07/2002 - 02/2002
1	Investigational DrugsIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Adenovirus VaccinesIBA 01/2021
1	VaccinesIBA 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021

Therapy/Procedure

31	Therapeutics 03/2024 - 02/2002
20	Critical Care (Surgical Intensive Care) 01/2020 - 05/2002
10	Length of Stay 03/2024 - 02/2002
7	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2008
5	Induced Hypothermia 04/2018 - 10/2011
4	Tracheostomy 10/2019 - 08/2015
4	Resuscitation 09/2017 - 03/2009
3	Erythrocyte Transfusion 01/2023 - 02/2016
3	Renal Replacement Therapy (Therapies, Renal Replacement) 04/2020 - 05/2019
3	Emergency Treatment 09/2017 - 09/2012
3	Activities of Daily Living (ADL) 06/2017 - 06/2009
2	Heart-Assist Devices 11/2020 - 04/2016
2	Induced Heart Arrest (Cardioplegia) 01/2020 - 01/2019
2	Defibrillators (Defibrillator) 01/2020 - 01/2019
2	Thrombectomy 01/2019 - 07/2017
2	Patient Readmission 01/2019 - 10/2015
2	Counterpulsation (External Counterpulsation) 01/2018 - 06/2016
2	Electrodes (Electrode) 10/2016 - 09/2009
2	Aftercare (After-Treatment) 11/2002 - 02/2002